Literature DB >> 9060820

Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.

P Parronchi1, P Romagnani, F Annunziato, S Sampognaro, A Becchio, L Giannarini, E Maggi, C Pupilli, F Tonelli, S Romagnani.   

Abstract

Crohn's disease (CD) is a chronic bowel inflammatory disorder in which the pathogenic role of immune alterations has been suggested, but the immunologic mechanisms responsible for the inflammatory reaction are still poorly understood. We investigated the profile of cytokine secretion by T-cell clones generated from gut tissue specimens of four patients with active CD, five patients with ulcerative colitis, and four patients with noninflammatory gut disorders (NIGDs). The great majority of CD4+ T-cell clones generated from the gut of patients with CD produced high levels of interferon-gamma (IFN-gamma) but low or undetectable amounts of interleukin-4 (IL-4), whereas substantial proportions of CD4+ T-cell clones derived from the gut of patients with either ulcerative colitis or NIGDs produced IL-4 in addition to IFN-gamma. The immunohistochemical analysis revealed high numbers of activated CD4+ T cells showing IFN-gamma but not IL-4 reactivity, as well as substantial proportions of IL-12-containing macrophages, in the intestinal lamina propria and muscularis propria of patients with CD, whereas these cells were very rare or undetectable in patients with NIGDs. Culturing T cells from gut biopsy specimens of a patient with CD in the presence of a neutralizing anti-IL-12 antibody down-regulated the development of IFN-gamma-producing CD4+ T cells. These findings suggest that a critical event in the initiation of bowel inflammatory lesions in CD may involve up-regulation of IL-12 production, resulting in conditions that maximally promote type 1 T-helper immune responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060820      PMCID: PMC1857889     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

Authors:  S Sad; R Marcotte; T R Mosmann
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

Review 3.  T cells in inflammatory bowel disease: protective and pathogenic roles.

Authors:  F Powrie
Journal:  Immunity       Date:  1995-08       Impact factor: 31.745

Review 4.  Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency.

Authors:  J Chehimi; G Trinchieri
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

Review 5.  Recent developments in nonspecific inflammatory bowel disease (second of two parts).

Authors:  J B Kirsner; R G Shorter
Journal:  N Engl J Med       Date:  1982-04-08       Impact factor: 91.245

6.  Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis.

Authors:  G F Del Prete; A Tiri; S Mariotti; A Pinchera; M Ricci; S Romagnani
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

7.  Peripheral blood and intestinal lymphocyte sub-populations in Crohn's disease.

Authors:  R G Strickland; G Husby; W C Black; R C Williams
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

8.  Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines.

Authors:  G Del Prete; M De Carli; F Almerigogna; C K Daniel; M M D'Elios; G Zancuoghi; F Vinante; G Pizzolo; S Romagnani
Journal:  FASEB J       Date:  1995-01       Impact factor: 5.191

9.  Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR).

Authors:  M Niessner; B A Volk
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

10.  Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy.

Authors:  M de Carli; M M D'Elios; S Mariotti; C Marcocci; A Pinchera; M Ricci; S Romagnani; G del Prete
Journal:  J Clin Endocrinol Metab       Date:  1993-11       Impact factor: 5.958

View more
  135 in total

Review 1.  Cytokines in experimental colitis.

Authors:  P Garside
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  Cytokine profiles in peripheral blood of children and adults with Crohn disease.

Authors:  Seung Pak; Nina Holland; Elizabeth A Garnett; Elizabeth Mileti; Uma Mahadevan; Rachel Beckert; Bittoo Kanwar; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-06       Impact factor: 2.839

Review 3.  Role of the innate immune system in the development of chronic colitis.

Authors:  Takanori Kanai; Ryoichi Ilyama; Takahiro Ishikura; Koji Uraushihara; Teruji Totsuka; Motomi Yamazaki; Tetsuya Nakamuma; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

4.  Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis.

Authors:  A Sturm; A Z A Leite; S Danese; K A Krivacic; G A West; S Mohr; J W Jacobberger; C Fiocchi
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

5.  Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies.

Authors:  P Manousou; G Kolios; V Valatas; I Drygiannakis; L Bourikas; K Pyrovolaki; I Koutroubakis; H A Papadaki; E Kouroumalis
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

6.  Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel disease.

Authors:  J Grundström; L Linton; S Thunberg; H Forsslund; I Janczewska; R Befrits; M van Hage; G Gafvelin; M Eberhardson
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

7.  Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

Authors:  B Szebeni; G Veres; A Dezsõfi; K Rusai; A Vannay; M Mraz; E Majorova; A Arató
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

8.  Acute appendicitis is characterized by a uniform and highly selective pattern of inflammatory gene expression.

Authors:  C G Murphy; J N Glickman; K Tomczak; Y Y Wang; A H Beggs; M W Shannon; B H Horwitz
Journal:  Mucosal Immunol       Date:  2008-07       Impact factor: 7.313

9.  TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis.

Authors:  B Del Zotto; G Mumolo; A M Pronio; C Montesani; R Tersigni; M Boirivant
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

10.  Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease.

Authors:  E M Coccia; M E Remoli; C Di Giacinto; B Del Zotto; E Giacomini; G Monteleone; M Boirivant
Journal:  Gut       Date:  2005-08-16       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.